RT @of_aic: Auto‐antibodies neutralizing type I interferons in COVID-19 patients : a not so rare finding but not associated with mortality…
RT @of_aic: Auto‐antibodies neutralizing type I interferons in COVID-19 patients : a not so rare finding but not associated with mortality…
of_aic: Auto‐antibodies neutralizing type I interferons in COVID-19 patients : a not so rare finding but not associated with mortality @Arrestier #COVID19 #Immunity #Prognosis #AIC #FICS #SRLF https://t.co/RJZIgOYmI4 https://t.co/uP3NKVxsyw
Auto‐antibodies neutralizing type I interferons in COVID-19 patients : a not so rare finding but not associated with mortality @Arrestier #COVID19 #Immunity #Prognosis #AIC #FICS #SRLF https://t.co/STQmhgj6a0 https://t.co/62f8kB79zC
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
7,073/ France (est. current tobacco smoking age 15+ was 28.7% in 2020) Of 925 critically ill COVID-19 patients in ICU, 13.4% were current smokers https://t.co/dYzYlrth9H
New NUTRITION Research Available. Click Here to Access Article(s): https://t.co/TB3rbOjFaJ
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
Auto-Abs neutralizing type I IFN-α2, β and/or ω were found in 96 patients
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
RT @NicolasdeProst1: Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in Fren…
Our article reporting the outcome of critically ill COVID-19 patients with auto-antibodies against type I IFNs in French ICUs is online ! Thanks to all co-authors and @casanova_lab for contributing! @APHP @GHUMondor https://t.co/jYXTYCoR2b https://t.co/7su